Unipolar depression (UD) and bipolar disorders are leading causes of disability worldwide.
1,2 Among patients with bipolar disorder, misdiagnosis rates of up to 75% are reported, primarily for UD,
3,4 leading to insufficient treatment, poor outcome, and higher health care costs.
5,6 There is a particular difficulty in distinguishing bipolar depression (BD) from UD, owing to their having the same diagnostic criteria for a depressive episode; the higher prevalence of depressive symptoms, rather than hypomanic symptoms, in bipolar disorder; and the presence of subthreshold manic symptoms for both disorders during a depressive episode.
7,8 A major research goal is thus to identify neurobiological markers that can help differentiate these disorders, especially for individuals presenting during depressive episodes.